Cellular senescence and the skeleton: pathophysiology and therapeutic implications
Open Access
- 1 February 2022
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 132 (3)
Abstract
Cellular senescence is a fundamental aging mechanism that is currently the focus of considerable interest as a pathway that could be targeted to ameliorate aging across multiple tissues, including the skeleton. There is now substantial evidence that senescent cells accumulate in the bone microenvironment with aging and that targeting these cells prevents age-related bone loss, at least in mice. Cellular senescence also plays important roles in mediating the skeletal fragility associated with diabetes mellitus, radiation, and chemotherapy. As such, there are ongoing efforts to develop “senolytic” drugs that kill senescent cells by targeting key survival mechanisms in these cells without affecting normal cells. Because senescent cells accumulate across tissues with aging, senolytics offer the attractive possibility of treating multiple age-related comorbidities simultaneously.Keywords
This publication has 97 references indexed in Scilit:
- The Hallmarks of AgingCell, 2013
- Depleting the methyltransferase Suv39h1 improves DNA repair and extends lifespan in a progeria mouse modelNature Communications, 2013
- Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancerEMBO Molecular Medicine, 2012
- Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescenceNature Communications, 2012
- Clearance of p16Ink4a-positive senescent cells delays ageing-associated disordersNature, 2011
- Bone fragility and decline in stem cells in prematurely aging DNA repair deficient trichothiodystrophy miceAGE, 2011
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and ArfGenes & Development, 2008
- Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosisAging Cell, 2007
- Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex SteroidsJournal of Biological Chemistry, 2007